Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SynAct Pharma Major Shareholding Notification 2024

May 8, 2024

3114_iss_2024-05-08_33c44592-432a-40a2-88b3-c8f9dfbf66a8.pdf

Major Shareholding Notification

Open in viewer

Opens in your device viewer

Issuer SynAct Pharma AB

Holder

NBCD A/S

Instrument

Instrument Share SE0008241491
Before the transaction
Shares 0
Voting rights 0
Transaction
Reason for major shareholding notification New share issue
Date 08/05/2024
Limit for number of shares 5 %
Limit for number of votes 5 %
After the transaction
Quantity
Shares 3,962,790
Directly held voting rights 3,962,790
Indirectly held voting rights 0
Percentage
Directly held shares 9.59595 %
Directly held voting rights 9.59595 %
Indirectly held voting rights 0 %

Resulting distribution of total holdings

Percentage of voting
rights:
Number of underlying
shares:
Shares 9.59595 % 3,962,790
Instruments - FITA Ch. 4, section 2, first
paragraph, line 2
Instruments - FITA Ch. 4, section 2,
first paragraph, line 3
- Physically settled
- Cash settled
Total 9.59595 % 3,962,790
Published
08/05/2024 12:47
Contact
Name
Filip Landenius
Phone
0735798786
Email [email protected]

CLOSE PRINT

[email protected] Tfn 08-408 980 37 Fax 08-24 39 25